Related Experiment Video
Updated: Mar 1, 2026
09:09
In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
2.3K
Sustainable platform for cross-disease evaluation: Integrated JCOG trials database (JCOG2509A).
Ryosuke Kita1, Noriko Mitome2, Junki Mizusawa2
1Japan Clinical Oncology Group Data Center/Operations Office, National Cancer Center Hospital, Tokyo, Japan; Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Summary
Japan Clinical Oncology Group (JCOG) is analyzing diverse clinical trial data to find common treatment patterns across cancers. This research aims to improve cancer care and clinical trial methods through integrated analysis and personalized treatment strategies.
Area of Science:
- Oncology
- Clinical Trials
- Biostatistics
Background:
- The Japan Clinical Oncology Group (JCOG) possesses extensive clinical trial data.
- Previous research often focused on specific cancer types or treatments.
Purpose of the Study:
- To perform integrated analyses of JCOG data across different cancer types and treatments.
- To identify commonalities and differences in treatment efficacy and safety.
- To inform personalized cancer treatment strategies and improve clinical trial methodology.
Main Methods:
- Cross-disease integrated analyses of existing JCOG clinical trial data.
- Subgroup analyses based on patient characteristics.
- Evaluation of treatment efficacy and safety.
Main Results:
- Analysis is ongoing; specific results will be reported upon completion.
- Identification of commonalities and differences in treatment efficacy and safety across cancer types.
- Factors influencing differential treatment outcomes and tolerability will be elucidated.
Conclusions:
- Integrated analysis of JCOG data can reveal cross-disease treatment insights.
- Findings will support evidence-based improvements in cancer treatment and clinical trial design.
- This approach contributes to personalized medicine in oncology.
Related Concept Videos
01:11Clinical Trials: Overview
5.2K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.2K
01:16Clinical Trials
11.0K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
11.0K
01:12Statistical Software for Data Analysis and Clinical Trials
1.7K
Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
1.7K
01:13Bioequivalence studies: Biowaivers
334
Body:In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
334
01:20Integrated Healthcare System
2.5K
An integrated healthcare system (IHS) is a set of organizations that provides for or arranges to provide coordinated and continuous service to a defined population. The IHS takes responsibility for that particular population's health status and outcome, both clinically and fiscally. An integrated healthcare system is a well-organized, well-coordinated, and collaborative network. The integrated delivery system is a network that connects different healthcare providers to deliver organized,...
2.5K
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
192
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
192